| Typicality: | 0.471 |
| Saliency: | 0.418 |
| in humans | 11 | other |
| in the us | 9 | location |
| in the uk | 8 | location |
| drug → be licensed for → use | 56 |
| drug → be licensed for → human use | 7 |
| drug → be licensed for → treatment | 3 |
| drug → licensed for → use | 3 |
| negative | neutral | positive |
| 0.207 | 0.653 | 0.141 |
| Raw frequency | 69 |
| Normalized frequency | 0.418 |
| Modifier score | 0.633 |
| Perplexity | 78.532 |